As of July 29
Training program
103Lecture of the President of the Cardiovascular Surgery Section Japanese
Thursday, October 2211:45-12:15
Room1, Main Hall, 1F, Kyoto International Conference Center
| Speaker: | Minoru Ono | (Department of Cardiovascular Surgery, The University of Tokyo) |
|---|
104Lecture of the President of the Thoracic Surgery Section Japanese
Tuesday, October 2013:20-13:50
Room1, Main Hall, 1F, Kyoto International Conference Center
| Chairperson: | Meinoshin Okumura | (Professor Emeritus, Osaka University/Director, Osaka Kaisei Hospital) |
|---|---|---|
| Speaker: | Masayoshi Inoue | (Department of Thoracic Surgery, Kyoto Prefectural University of Medicine) |
105Lecture of the President of the Esophageal Surgery Section Japanese
Wednesday, October 2113:25-13:55
Room1, Main Hall, 1F, Kyoto International Conference Center
| Chairperson: | Yuko Kitagawa | (Executive Vice-President, Keio University) |
|---|---|---|
| Speaker: | Hiroya Takeuchi | (Department of Surgery, Hamamatsu University School of Medicine) |
101Presidential Address Japanese
Wednesday, October 2112:50-13:20
Room1, Main Hall, 1F, Kyoto International Conference Center
| Chairperson: | Masayuki Chida | (Dpartment of General Thoracic Surgery, Dokkyo Medical University) |
|---|---|---|
| Speaker: | Hideyuki Shimizu | (Department of Cardiovascular surgery, Keio University school of medicine) |
102President’s Program Japanese
Wednesday, October 2114:05-15:05
Room1, Main Hall, 1F, Kyoto International Conference Center
106Special Lecture1 Japanese
To the Moon, More Space Tourism!
Space Medicine and Surgeons will Become Even More Important
Tuesday, October 2013:55-14:25
Room1, Main Hall, 1F, Kyoto International Conference Center
| Chairperson: | Minoru Ono | (Department of Cardiovascular Surgery, The University of Tokyo) |
|---|---|---|
| Speaker: | Satoshi Furukawa | (Life Science Research Center, Kyorin University) |
107Special Lecture2 Japanese
Thursday, October 2211:10-11:40
Room1, Main Hall, 1F, Kyoto International Conference Center
| Chairperson: | Masayoshi Inoue | (Department of Thoracic Surgery, Kyoto Prefectural University of Medicine) |
|---|---|---|
| Speaker: | Koshunji Tatekawa | (Rakugo-ka) |
Cross‑disciplinary
202Symposium1 Japanese
Application of artificial intelligence to cardiovascular and thoracic surgery
Tuesday, October 208:00-9:30
Room2, Room A, 2F, Kyoto International Conference Center
201Symposium2 Japanese
Medical device development for the treatment of thoracic disease
Tuesday, October 2010:40-12:10
Room2, Room A, 2F, Kyoto International Conference Center
205Panel Discussion1 Japanese
Intraoperative troubleshooting in robot-assisted surgery in the field of thoracic surgery
Wednesday, October 2116:30-18:00
Room3, Room B-1, 2F, Kyoto International Conference Center
204Panel Discussion2 Japanese
Current Status and Future Prospects of Task-Sharing in Donation of Brain-Dead Donor Hearts and Lungs
Thursday, October 229:20-11:00
Room7, Room C-1, 1F, Kyoto International Conference Center
203Workshop Japanese
Joint thoracic surgery for locally advanced thoracic malignancies: perioperative treatment, adjacent organ resection, cardiopulmonary support, and aortic stenting
Wednesday, October 219:10-10:40
Room2, Room A, 2F, Kyoto International Conference Center
Cardiac
310Symposium1 English
Rhythm or Protection? Surgical Decision-making in LSPAF: Maze vs. Beating-heart LAA Closure
Tuesday, October 208:00-9:30
Room1, Main Hall, 1F, Kyoto International Conference Center
- Outline
- The Cox-Maze procedure is well established as an effective surgical intervention for restoring sinus rhythm in patients with long-standing persistent atrial fibrillation (LSPAF). However, large-scale clinical trials such as the AFFIRM study have demonstrated no significant difference in prognosis or quality of life (QOL) between rhythm control strategies—aiming for sinus rhythm—and rate control strategies in patients with both paroxysmal and persistent AF.
In recent years, the development of novel occlusion devices has enabled left atrial appendage (LAA) closure to be performed on the beating heart without the use of cardiopulmonary bypass. This advancement has led to a growing interest in stroke prevention strategies that do not aim for rhythm control but instead rely on rate control combined with LAA closure.
This session will bring together leading experts from Japan and the United States to engage in an in-depth discussion on the optimal surgical approach for LSPAF: Should we pursue rhythm control through the Maze procedure, or is rate control with beating-heart LAA closure sufficient? Through this transpacific dialogue, we aim to clarify the future direction of surgical management for LSPAF.
308Symposium2 Japanese
Translational Advances in Cardiothoracic Surgery: The Role of Large Animal Models in Biomedical Innovation
Tuesday, October 208:00-9:30
Room3, Room B-1, 2F, Kyoto International Conference Center
309Symposium3 Japanese
Contemporary Evidence-Based Approaches to SAVR and TAVR in Low-Risk Patients
Tuesday, October 208:00-9:30
Room5, Sakura, 1F, Kyoto International Conference Center
305Symposium4 Japanese
Lifetime Management and Surgical Strategy for Acute Type A Aortic Dissection
Tuesday, October 209:35-11:05
Room1, Main Hall, 1F, Kyoto International Conference Center
307Symposium5 English
The Next Generation of Heart Transplantation
Tuesday, October 209:35-10:35
Room2, Room A, 2F, Kyoto International Conference Center
- Outline
- Innovative approaches to heart transplantation—such as donation after circulatory death (DCD), beating heart transplantation, and combined organ transplantation—are rapidly gaining ground worldwide. In this symposium, we will welcome Dr. Akinobu Itoh from Brigham and Women’s Hospital and Dr. Joseph Woo from Stanford University, who will share the latest advances in DCD and beating heart transplantation, respectively. By exploring global trends and cutting-edge bench-to-bedside research, we aim to discuss the future direction of heart transplantation in Japan. We invite enthusiastic submissions that align with the theme and contribute to shaping the next era of cardiac transplant therapy.
301Symposium6 English
Clinical management of ischemic heart disease in light of upcoming guideline updates
Tuesday, October 2011:10-12:10
Room3, Room B-1, 2F, Kyoto International Conference Center
- Outline
- In light of changes and ongoing discussions in healthcare systems following the revision of Western guidelines for chronic coronary artery disease, this study aims to foresee the future direction of clinical guideline updates for chronic coronary syndromes in Japan.
303Symposium7 Japanese
Mechanical circulatory support in single ventricle
Tuesday, October 2011:10-12:10
Room4, Room B-2, 2F, Kyoto International Conference Center
306Symposium8 Japanese
Lifetime management of aortic diseases with genetic background
Tuesday, October 2015:30-16:30
Room1, Main Hall, 1F, Kyoto International Conference Center
302Symposium9 Japanese
Ischemia assessment in CABG (FFR,NHPR,etc)
Tuesday, October 2016:30-17:30
Room2, Room A, 2F, Kyoto International Conference Center
304Symposium10 Japanese
Surgery for right heart valve in adult congenital heart disease
Tuesday, October 2016:30-17:30
Room3, Room B-1, 2F, Kyoto International Conference Center
311Video Symposium Japanese
3D Models: Visualization Aids or Decision-Making Tools? A Reevaluation of the Clinical Utility of 3D Simulation
Tuesday, October 209:35-11:05
Room5, Sakura, 1F, Kyoto International Conference Center
315Panel Discussion1 Japanese
The Pros and Cons of Preemptive TEVAR
Tuesday, October 2011:10-12:10
Room5, Sakura, 1F, Kyoto International Conference Center
319Panel Discussion2 Japanese
How to treat severe TR with right heart failure: Approaching the indications and limitations of catheter treatment and surgery
Tuesday, October 2016:30-17:30
Room5, Sakura, 1F, Kyoto International Conference Center
313Panel Discussion3 Japanese
Perioperative Management of CABG to Reduce Surgical Site Infection
Wednesday, October 218:00-9:30
Room3, Room B-1, 2F, Kyoto International Conference Center
314Panel Discussion4 English
Surgical strategies for congenital aortic valve disease
Wednesday, October 2114:05-15:35
Room4, Room B-2, 2F, Kyoto International Conference Center
- Outline
- Aortic valve repair for congenital aortic valve disease, including autologous pericardial reconstruction and the Ozaki procedure shows favorable early outcomes. However, long-term durability remains a challenge that warrants discussion. In addition, we encourage institutions to share and discuss strategies for improving autograft durability in Ross procedures, optimal timing for surgical intervention, and technical innovations.
316Panel Discussion5 English
Advanced Surgical Strategies for High-Risk Patients with Thoracoabdominal Aortic Aneurysms
Wednesday, October 2114:05-15:35
Room5, Sakura, 1F, Kyoto International Conference Center
- Outline
- In this session, we will discuss indications and strategic approaches for thoracoabdominal aortic aneurysm (TAAA) repair in patients with multiple high-risk factors—such as age over 80, frailty, shaggy aorta, dialysis dependence, and reoperations. Experts from multiple institutions will share their perspectives, allowing for a multifaceted discussion.
We aim to contrast international trends with the current situation in Japan and examine which approach—open surgery, hybrid procedures, or conservative/palliative treatment—should be selected based on clinical evidence and real-world experience. The session will provide a platform for an in-depth discussion on how to manage these complex cases in contemporary practice.
318Panel Discussion6 English
Root replacement at boderline age. Native valve vs Prosthetic valve
Wednesday, October 2116:30-18:00
Room1, Main Hall, 1F, Kyoto International Conference Center
- Outline
- Regardless of the severity of aortic regurgitation (AR), various surgical techniques are available for the treatment of annulo-aortic ectasia (AAE). Valve-sparing root replacement (VSRR) is recommended for younger patients; however, in Japan, there are few institutions that meet the guideline-defined criteria for an “experienced center,” and avoiding reoperation due to recurrent valve regurgitation remains a concern.
Meanwhile, with the expanded indications for bioprosthetic valves, bioprosthetic composite valve graft aortic root replacement (CVG-ARR) has become a viable option. However, comparative long-term outcome data among bioprosthetic CVG-ARR, mechanical valve CVG-ARR, and VSRR remain insufficient. In this session, we aim to explore the indications and limitations of VSRR in patients around the borderline age of 60 and in cases with cusp degeneration, as well as the criteria for selecting among different types of CVG-ARR.
317Panel Discussion7 Japanese
Current Status and Challenges of Destination Therapy
Wednesday, October 2116:30-18:00
Room4, Room B-2, 2F, Kyoto International Conference Center
312Panel Discussion8 Japanese
Real world in CABG (multi-vessel? MICS? OPCAB? ONCAB?)
Wednesday, October 2116:30-18:00
Room5, Sakura, 1F, Kyoto International Conference Center
322Workshop1 Japanese
Surgical Management of Congenital Coronary Artery Anomalies and Arteriovenous Fistulas
Tuesday, October 208:00-9:00
Room4, Room B-2, 2F, Kyoto International Conference Center
327Workshop2 Japanese
Optimal anticoagulation therapy after surgical left atrial appendage closure
Tuesday, October 2016:30-17:30
Room4, Room B-2, 2F, Kyoto International Conference Center
326Workshop3 Japanese
New Frontiers in Translational Cardiac Surgery Enabled by Next-Generation Technologies
Wednesday, October 218:00-9:00
Room2, Room A, 2F, Kyoto International Conference Center
325Workshop4 English
Reconsider Aortic Valve Surgeries related to LVAD
Wednesday, October 2115:20-16:20
Room1, Main Hall, 1F, Kyoto International Conference Center
- Outline
- In aortic valve insufficiency under VAD circulation, quantitative assessment is challenging, leading to decisions on the necessity of aortic valve intervention being determined by institutional guidelines. The severity diagnosis and impact on hemodynamics differ from those in aortic valve insufficiency under physiological pulsatile circulation, rendering existing diagnostic criteria inapplicable.In this regard, aortic valve insufficiency under LVAD circulation can be considered a “new valvular disease.” That is, it requires a different perspective from existing aortic valve insufficiency. Furthermore, a history of treatment with Impella has been suggested to be associated with the onset or worsening of aortic regurgitation under LVAD circulation, and the treatment history leading up to LVAD further complicates the decision regarding intervention.For this “new valvular disease,” aortic valve repair, aortic valve reconstruction (including Park’s stitch), and aortic valve replacement are selected based on institutional criteria. Here, we aim to re-evaluate LVAD-related aortic valve surgery from a surgical perspective, focusing on whether each procedure effectively controlled aortic regurgitation in the long term and whether there are differences between procedures.
323Workshop5 Japanese
Innovations in Aortic Treatment Brought by Advances in Imaging Modalities
Thursday, October 229:30-11:00
Room2, Room A, 2F, Kyoto International Conference Center
321Workshop6 Japanese
Systemic pulmonary shunt: Future prospects
Thursday, October 229:30-11:00
Room3, Room B-1, 2F, Kyoto International Conference Center
324Workshop7 Japanese
Impella as a Potential Therapeutic Standard in Heart Failure Management — Exploring Its Scope and Limitations from Acute to Chronic Phases
Thursday, October 229:30-11:00
Room5, Sakura, 1F, Kyoto International Conference Center
320Workshop8 Japanese
MCS in CABG: State-of-the-Art Strategies
Thursday, October 2214:30-15:30
Room6, Room C-2, 1F, Kyoto International Conference Center
328Video Workshop Japanese
Technical challenges in valve repair for infective endocarditis
Thursday, October 2214:30-15:30
Room5, Sakura, 1F, Kyoto International Conference Center
330JATS/STS Joint Symposium English
Tuesday, October 209:35-11:05
Room3, Room B-1, 2F, Kyoto International Conference Center
329JATS-JSMP Joint Symposium Japanese
Fundamentals and key principles of myocardial protection during prolonged ischemia: Lessons from heart preservation for transplantation.
Wednesday, October 2116:30-18:00
Room2, Room A, 2F, Kyoto International Conference Center
Lung
401Symposium1 English
Treatment outcomes and clinical impact of the TNM classification 9th edition for thymic epithelial tumors
Tuesday, October 208:00-9:30
Room8, Room D, 1F, Kyoto International Conference Center
- Outline
- In 2025, the TNM classification for thymic epithelial tumors was revised for the first time and is now being used in clinical practice. Tumor size has been newly incorporated into the T factor, and phrenic nerve invasion and lung invasion, which were previously classified as T3, have been changed to T2. There has been no change in the staging logic, but the survival curves by disease stage and the suitable postoperative treatment may have changed. In addition, while many treatment results have been reported using the Masaoka classification, in the future, evidence of treatment based on the TNM classification will be required. In this symposium, we will discuss whether the treatment results and policies in each institutes, including whether the addition of the new TNM staging classification to the WHO histological classification, a traditional pathological prognostic factor, will have an impact on the treatment of thymomas, thymic carcinomas, and thymic neuroendocrine tumors.
402Symposium2 English
Contemporary Indications and Clinical Significance of Pneumonectomy in Lung Cancer
Tuesday, October 2015:40-17:10
Room8, Room D, 1F, Kyoto International Conference Center
- Outline
- Recent advancements in non-surgical therapies for lung cancer—including high-dose radiotherapy, chemoradiotherapy, immunotherapy, and molecular targeted agents—have led to an increased number of opportunities for salvage surgery. In many of these cases, pneumonectomy is required due to the extent and location of the residual disease. However, the clinical significance and optimal role of pneumonectomy in this setting remain controversial and are yet to be clearly defined. In addition, completion pneumonectomy is occasionally performed for complications arising from multimodal treatment, including medical, surgical, and radiation therapies. Given the marked decline in the number of pneumonectomies performed for lung cancer in Japan in recent years, it is timely and necessary to re-examine and discuss the contemporary indications and value of this procedure.
405Panel Discussion1 Japanese
Impact of COVID-19 infection on lung transplant recipients: onset, association with CLAD, and prognosis
Tuesday, October 208:00-9:30
Room9, Room E, 1F, Kyoto International Conference Center
404Panel Discussion2 Japanese
Exploring future strategies in pneumothorax: Recurrence prevention and management of secondary refractory cases
Tuesday, October 209:35-11:05
Room8, Room D, 1F, Kyoto International Conference Center
406Panel Discussion3 Japanese
Mid- to Long-Term Outcomes of Minimally Invasive Surgery for Patients with Thymic Epithelial Tumors
Tuesday, October 209:35-11:05
Room9, Room E, 1F, Kyoto International Conference Center
408Panel Discussion4 Japanese
Preventive measures and Management of Postoperative Complications Following Extended Surgery
Tuesday, October 2011:10-12:10
Room9, Room E, 1F, Kyoto International Conference Center
409Panel Discussion5 Japanese
Optimizing Surgical Training for Thoracic Surgeons in the New Workstyle Era
Wednesday, October 2114:05-15:35
Room6, Room C-2, 1F, Kyoto International Conference Center
407Panel Discussion6 Japanese
Challenging Surgery through a Minimally Invasive Approach
Wednesday, October 2114:05-15:05
Room7, Room C-1, 1F, Kyoto International Conference Center
410Panel Discussion7 English
Shaping the Surgeon: Global and Domestic Fellowships That Made the Difference
Wednesday, October 2116:30-18:00
Room6, Room C-2, 1F, Kyoto International Conference Center
- Outline
- In this session, we will focus on domestic and international study and fellowship experiences that have significantly influenced the careers of thoracic surgeons. Beyond clinical practice and basic research, the presentations will highlight multidimensional growth, including the development of clinical perspectives, research attitudes, and global outlooks. By sharing how insights gained through exposure to different cultures and healthcare systems have shaped the presenters’ current activities in clinical practice, education, and research, we aim to discuss the value of such cross-border experiences in nurturing the next generation of thoracic surgeons.
411Panel Discussion8 English
Salvage surgery for local recurrence after segmentectomy for lung cancer
Wednesday, October 2116:30-18:00
Room8, Room D, 1F, Kyoto International Conference Center
- Outline
- Based on the results of the JCOG0802 and CALGB140503 trials, the proportion of segmentectomy for lung cancer surgeries in Japan is on an upward trend. However, local recurrence is more common after segmentectomy than after lobectomy. Therefore, it is essential to develop treatments for local recurrence and establish optimal treatment strategies for this condition. Surgical treatment for local recurrence is particularly technically challenging, and careful consideration is required when selecting surgical procedures and determining the feasibility of resection.
In this session, we invite you to share your treatment outcomes and strategies for local recurrence after segmentectomy, presenting practical approaches and innovations in salvage surgery for challenging cases. This will improve our understanding of the indications for and case selection in segmentectomy for lung cancer.
417Workshop1 Japanese
Current status of simulation education and training
Tuesday, October 2011:10-12:10
Room8, Room D, 1F, Kyoto International Conference Center
416Workshop2 Japanese
The role of surgery in the multimodality treatment of mediastinal germ cell tumor
Wednesday, October 219:50-10:50
Room7, Room C-1, 1F, Kyoto International Conference Center
414Workshop3 English
Innovations and New Techniques in Lung Transplantation
Wednesday, October 2114:05-15:35
Room8, Room D, 1F, Kyoto International Conference Center
- Outline
- Although lung transplantation may appear to be a standardized procedure, various innovations and new technologies are continuously being introduced. By sharing recent technical updates from each institution, we aim to contribute to the overall progress of lung transplantation in Japan.
413Workshop4 Japanese
Reconsidering treatment strategies for bronchopleural fistula
Wednesday, October 2116:00-17:00
Room7, Room C-1, 1F, Kyoto International Conference Center
412Workshop5 Japanese
Surgical treatment strategies for pulmonary infectious diseases:~evaluation of surgical indications and extent of resection, and techniques for reducing perioperative complications
Wednesday, October 2117:00-18:00
Room7, Room C-1, 1F, Kyoto International Conference Center
418Workshop6 Japanese
Surgical strategies for challenging cases after ICI and TKI treatment in lung cancer
Thursday, October 229:30-11:00
Room8, Room D, 1F, Kyoto International Conference Center
420Workshop7 Japanese
Ongoing Lung Cancer Surgical Clinical Trials
Thursday, October 229:30-10:30
Room9, Room E, 1F, Kyoto International Conference Center
415Workshop8 Japanese
Novel findings of lung transplantation from Japan
Thursday, October 2214:30-15:30
Room7, Room C-1, 1F, Kyoto International Conference Center
419Workshop9 Japanese
Facing the Rising Challenge of High-Risk Cases: Limits and Perspectives in Lung Cancer Surgery
Thursday, October 2214:30-15:30
Room9, Room E, 1F, Kyoto International Conference Center
421Japanese Joint Committee of Lung Cancer Registration Japanese
Thursday, October 2210:30-11:00
Room9, Room E, 1F, Kyoto International Conference Center
Esophagus
502Symposium1 Japanese
Surgical Techniques and Treatment Outcomes of Robot-Assisted Esophagectomy
Tuesday, October 208:00-9:30
Room10, Swan, 1F, Kyoto International Conference Center
501Symposium2 Japanese
Traetment strategy for cT3br/T4 esophageal cancer
Tuesday, October 209:35-11:05
Room10, Swan, 1F, Kyoto International Conference Center
503Panel Discussion1 Japanese
Indications and Pitfalls of Conversion Surgery for Esophageal and Esophagogastric Junction Cancer
Tuesday, October 2016:00-17:30
Room10, Swan, 1F, Kyoto International Conference Center
504Panel Discussion2 Japanese
Treatment Strategies for Super-Elderly Patients with Esophageal Cancer
Wednesday, October 218:00-9:00
Room9, Room E, 1F, Kyoto International Conference Center
505Panel Discussion3 Japanese
Best choice for gastric tube reconstruction after esophagectomy:Ivor Lewis vs. McKeown method
Wednesday, October 2114:05-15:35
Room9, Room E, 1F, Kyoto International Conference Center
508Workshop1 Japanese
Troubleshooting for Mediastinoscopic Esophagectomy
Wednesday, October 218:00-9:30
Room10, Swan, 1F, Kyoto International Conference Center
506Workshop2 Japanese
Training Program for Young Esophageal Surgeons in the Era of Robot-Assisted Surgery
Wednesday, October 219:50-10:50
Room9, Room E, 1F, Kyoto International Conference Center
507Workshop3 Japanese
Techniques for gastric tube reconstruction after esophagectomy
Thursday, October 229:30-11:00
Room10, Swan, 1F, Kyoto International Conference Center
509Video Session Japanese
Left recurrent laryngeal nerve lymph node dissection ~Video clinic with unedited videos~
Tuesday, October 2011:10-12:10
Room10, Swan, 1F, Kyoto International Conference Center
510JATS/JES/JSES Joint Seminor Japanese
Pathway to Certification: JES board certified esophageal surgeon and JSES qualified surgeon
Thursday, October 2214:30-15:30
Room10, Swan, 1F, Kyoto International Conference Center
